Carl Wittkopp

Carl Wittkopp writes for Money Morning and has a diploma in Financial Planning. He specialises in technical analysis.

Thinking of an ASX 200 ETF? Where to Look for Opportunities

You may be thinking of buying an ASX 200 ETF that tracks the overall performance of [XJO] which is the ticker symbol for the index. So let’s take a look at what the ASX is up to, and where the best investment opportunities could be in the context of recent market moves....

New BetaShares ETF Follows Online Sales Boom (ASX:ATEC)

BetaShares released this new product in March 2020. It’s called ATEC [ASX:ATEC]. Trading at $17.36 at the time of writing, the ATEC fund is making an explosive start to life. But will it last? Like all ETFs, ATEC is a collection of stocks grouped together in one tradable product...

AD1 Share Price Up on Strong Results (ASX:AD1)

The Melbourne-based technology company jumped up over 27% on the back of strong performance. Trading at $0.037 at the time of writing, the AD1 Holdings Ltd [ASX:AD1] share price retraced following an announcement at the start of this month...

Kogan Is Booming on Recent Results (ASX:KGN)

At time of writing, the Kogan.com Ltd [ASX:KGN] share price sits at $17.06, trading close to its all-time high of $18.35. While many businesses are struggling in the current climate, Kogan is standing out as a clear winner...

ASX Weekly Market Outlook and the Top Movers Last Week:

With the All Ordinaries [XAO] unable to create a new high the last week, the outlook for the ASX this coming week looks to be more of the same as the market sets into a sideways movement for the time being. The market will pick a direction soon enough, right now we must wait...

Incannex Healthcare Ltd Posts Record Sales (ASX:IHL)

From the low in April 2020, the share price has moved up over 138% to where it is today, all this on the back of a rather exciting 12 months for the company. Looking back to August 2019, Impressions Healthcare announced they had officially launched their wholly-owned, novel cannabinoid drug discovery brand, Incannex...
Money Morning Australia